1. Home
  2. TNXP vs EPSN Comparison

TNXP vs EPSN Comparison

Compare TNXP & EPSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

N/A

Current Price

$9.26

Market Cap

199.7M

Sector

Health Care

ML Signal

N/A

Logo Epsilon Energy Ltd.

EPSN

Epsilon Energy Ltd.

N/A

Current Price

$5.92

Market Cap

187.2M

Sector

Energy

ML Signal

N/A

Company Overview

Basic Information
Metric
TNXP
EPSN
Founded
2007
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
199.7M
187.2M
IPO Year
2008
2018

Fundamental Metrics

Financial Performance
Metric
TNXP
EPSN
Price
$9.26
$5.92
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $44.50
N/A
AVG Volume (30 Days)
★ 374.3K
110.0K
Earning Date
11-09-2026
11-04-2026
Dividend Yield
N/A
★ 4.31%
EPS Growth
★ 91.75
N/A
EPS
N/A
★ 0.26
Revenue
★ $13,107,000.00
N/A
Revenue This Year
$319.65
N/A
Revenue Next Year
$101.60
N/A
P/E Ratio
★ N/A
$22.31
Revenue Growth
★ 29.85
N/A
52 Week Low
$9.40
$4.20
52 Week High
$24.64
$6.65

Technical Indicators

Market Signals
Indicator
TNXP
EPSN
Relative Strength Index (RSI) 26.70 44.36
Support Level $9.40 $5.53
Resistance Level $12.99 $5.97
Average True Range (ATR) 0.50 0.23
MACD -0.18 -0.05
Stochastic Oscillator 3.73 11.84

Price Performance

Historical Comparison
TNXP
EPSN

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.

About EPSN Epsilon Energy Ltd.

Epsilon Energy Ltd is a North American on-shore focused independent natural gas and oil company engaged in the acquisition, development, gathering and production of natural gas and oil reserves. Its properties include Appalachian Basin-Pennsylvania, Permian Basin-Texas and New Mexico, Anadarko Basin-Oklahoma, Powder River Basin-Wyoming, Western Canadian Sedimentary Basin-Alberta, Canada. Its segments include The Upstream segment activities include acquisition, development and production of natural gas and oil reserves on properties within the United States and Canada; and The Gas Gathering segment partners with two other companies to operate a natural gas gathering system. The Upstream segment derives the majority of the revenue.

Share on Social Networks: